UBS Group »

Mineralys Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Mineralys Therapeutics

Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 2025200k400k600k10k20k30k40k50k
Value ($)Share countHistorical MLYS position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $602k 49k 12.31
2024-09-30 $195k 16k 12.11
2024-06-30 $126k 11k 11.70
2024-03-31 $255k 20k 12.91
2023-12-31 $186k 22k 8.60
2023-09-30 $72k 7.5k 9.53
2023-06-30 $137k 8.0k 17.05